ASML's High-NA Lead Widens as Alstom Cuts Forecasts — Goldman Sachs on Peak Growth
$ASML $ALSO.PA
$BTC GOLDMAN SACHS GLOBAL INVESTMENT RESEARCH | SAHAR ISLAM, ALEXANDER DUVAL, DANIELA COSTA • 19 November 2026
1. What did Goldman Sachs find at ASML's Wilton site?
• Goldman Sachs toured ASML's Wilton facility in Connecticut with investors, hosted by operations chief Louis Lu and investor-relations director Peter Convertito.
• Strong momentum on High NA and the associated ecosystem — the next-generation lithography platform behind leading-edge chips.
• A deep competitive moat gives a sustainable long-term advantage, with multiple avenues for output optimisation over time.
• Installed-base management and the upgrades business should see strong momentum; Match Act concerns are overdone, in Goldman Sachs' view.
• Goldman Sachs reiterates Buy (on Conviction List) with 83% upside.
2. Why is Alstom the other side of the trade?
• Goldman Sachs revisited Alstom after its 1H26/27 results — and its 3 November profit warning — cutting 27/28/29E group aEBIT post JV by 34%/6%/6% on weaker margins and lower JV earnings.
• Visibility on the backlog problems is still limited, though new disclosure breaking the backlog down by project stage helps narrow the scope of the issues.
• Alstom holds stakes in five JVs/associates — three in China, one in France, one in Spain — now valued at €1.2–1.7bn (from €1.4–2.1bn), excluding the loss-making ADEME JV.
• Rating stays Sell.
3. What does “balance around peak growth” mean for 2027?
• In its 2027 outlook, Goldman Sachs stays modestly pro-risk but favours more balance across and within assets as nominal and earnings growth approach a peak after the AI capex boom and 2026's energy-driven inflation boost.
• Opportunities should broaden beyond AI capex beneficiaries toward applications, adoption and productivity gains.
• Goldman Sachs favours selective growth exposure alongside quality, defensive and high dividend/buyback stocks — and sees bonds as a better buffer as nominal growth peaks.
4. What are the risks — and what should investors watch?
• Near-term risks remain elevated: AI concerns, renewed energy shocks, more aggressive Fed tightening and persistent fiscal concerns.
• For ASML, whether High-NA momentum converts into output and upgrade revenues; for Alstom, backlog clarity and the value realised from its JV stakes.
• Also in the same note: Argenx's December readout of empasiprubart's Phase 3 EMPASSION trial — Goldman Sachs is optimistic, with non-inferiority as the base case and superiority as the bull case; Buy (on Conviction List), 11% upside.
Since the report (20 Nov): AI stocks sold off sharply — Nvidia fell 12.5% on Friday after its earnings beat, and the Nasdaq hit multimonth lows — a reminder that even a High-NA leader is not immune to an AI valuation reset. (Market reports, 20–21 Nov 2026.)
#Semiconductors #AI #HighNA #ASML #Alstom
Source: Goldman Sachs, 19 November 2026. Based solely on the report provided; forecasts are not guaranteed. For reference only; not investment advice.
Read the full breakdown on Unhidea: https://unhidea.com/en/articles/research-4c96041c25df47969e9ff4bfb9abe032-en
Visit unhidea.com for more of the latest sell-side research interpretations.